Abeona Therapeutics (NASDAQ:ABEO) Upgraded at StockNews.com
StockNews.com upgraded shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a sell rating to a hold rating in a report published on Monday morning. Other equities research analysts also recently issued research reports about the company. HC Wainwright reissued a “buy” rating and issued a $15.00 price target on shares of Abeona Therapeutics in […]
